17 results
8-K
EX-99.1
ACXP
Acurx Pharmaceuticals, Inc.
9 Aug 24
Acurx Pharmaceuticals, Inc. Reports Second Quarter 2024 Results and Provides Business Update
7:13am
in the European Union, the United Kingdom, Japan and Canada.
Also in April 2024, we attended the European Society of Microbiology and Infectious Disease
8-K
EX-1.1
ihz8lqryveupqdn3
15 Nov 23
Entry into a Material Definitive Agreement
5:02pm
PRE 14A
b8d6fdec3d0fwqu
17 Apr 23
Preliminary proxy
4:05pm
DEF 14A
a8f6y
25 Apr 22
Definitive proxy
4:06pm
10-K
uy5xwp
16 Mar 22
Annual report
4:05pm
424B4
tgyz8 pk6
28 Jun 21
Prospectus supplement with pricing info
6:02am
S-1/A
pllld1f
11 Jun 21
IPO registration (amended)
6:02am
S-1
EX-10.10
0d2nzg nlh
27 May 21
IPO registration
12:00am
S-1
vnlv1cj097v1 l3
27 May 21
IPO registration
12:00am
DRS/A
9s2p2jes9yvkb40
10 May 21
Draft registration statement (amended)
12:00am
DRS/A
EX-10.10
uho3tov
10 May 21
Draft registration statement (amended)
12:00am
DRS
u8leb txb
5 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next